1. European Urology Oncology
Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes 
Luca Boeri, Matteo Soligo, Igor Frank, Stephen A. Boorjian, R. Houston Thompson, Matthew Tollefson, Fernando J. Quevedo, John C. Cheville, R. Jeffrey Karnes 
European Urology Oncology 
DOI: /j.euo
Copyright © 2018 European Association of Urology Terms and Conditions

2. Fig. 1
Kaplan-Meier plots depicting the overall mortality (OM)-free rate among patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy between 1999 and 2015 at a single centre, stratified according to time to cystectomy (TTC; >10wk vs ≤10wk).
European Urology Oncology DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions

3. Fig. 2
Kaplan-Meier plots depicting the cancer-specific mortality (CSM)-free rate among patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy between 1999 and 2015 at a single centre, stratified according to time to cystectomy (TTC; >10wk vs ≤10wk).
European Urology Oncology DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions